West Pharmaceutical Services revenue and financials
$372.64Change from previous close: −1.09%Absolute change: −$4.12
In the fiscal year ended December 2025, West Pharmaceutical Services reported revenue of $3.07B (+6.25% year over year). Net income was $493.7M, a net margin of 16.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.25%
- 2025 vs 2024
- Net income growth
- +0.20%
- 2025 vs 2024
- Net margin
- 16.1%
- 2024: 17.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 | 2,794 | 2,341 | 1,979 | 1,863 | 1,717 |
| Current assets | 1,978 | 1,538 | 1,936 | 1,920 | 1,742 | 1,374 | 1,059 | 894 | 744 | 642 |
| Cash and equivalents | 791 | 485 | 854 | 894 | 763 | 616 | 439 | 337 | 236 | 203 |
| Receivables | 586 | 576 | 534 | 524 | 504 | — | — | — | — | — |
| Inventory | 444 | 377 | 435 | 415 | 378 | — | — | — | — | — |
| Net property, plant and equipment | 1,878 | 1,716 | 1,513 | 1,263 | 1,127 | — | — | — | — | — |
| Goodwill | 110 | 106 | 109 | 107 | 110 | 111 | 108 | 106 | 108 | 103 |
| Other intangible assets | 7.7 | 10.8 | 15.1 | 18.4 | 23.0 | — | — | — | — | — |
| Long-term investments | 212 | 202 | 210 | 205 | 208 | — | — | — | — | — |
| Current liabilities | 655 | 550 | 672 | 519 | 594 | 503 | 342 | 284 | 280 | 241 |
| Accounts payable | 254 | 239 | 242 | 215 | 232 | — | — | — | — | — |
| Long-term debt | 203 | 203 | 207 | 209 | 253 | 255 | 255 | 196 | 197 | 229 |
| Total debt | 321 | 302 | 309 | 318 | — | — | — | — | — | — |
| Total liabilities | 1,094 | 961 | 949 | 932 | 978 | 939 | 768 | 583 | 583 | 599 |
| Total equity (incl. minority) | 3,176 | 2,682 | 2,881 | 2,685 | 2,335 | — | — | — | — | — |
| Retained earnings | 4,375 | 3,957 | 3,523 | 2,988 | 2,457 | — | — | — | — | — |